Join Dr. Sam Merriel, a GP in North-West England and NIHR Academic Clinical Lecturer at the University of Manchester, for an insightful session on the PSA Consensus Statement and its implications for prostate cancer screening.
Dr. Merriel brings a wealth of expertise from his role as an Associate Editor of the British Journal of General Practice and his extensive research in early cancer detection and prevention within primary care. He will delve into the critical context and rationale behind the PSA Consensus Statement, discussing which key statements garnered consensus and which did not, providing clarity on the challenges and debates within the field.
By watching this session, you will gain a deeper understanding of high-risk groups for prostate cancer, learning about their unique screening requirements. Dr. Merriel will also outline practical strategies for implementing the PSA Consensus Statement in clinical settings, equipping healthcare professionals with the knowledge to enhance patient outcomes.
With a background that includes significant contributions to NICE’s prostate cancer guidelines and various expert reference groups, Dr. Merriel’s insights are invaluable for anyone involved in prostate cancer diagnosis and management.
This session promises to enrich your understanding and application of prostate cancer screening in your practice, ultimately leading to better patient care and outcomes.
